Profil
Charles Ruban worked as Vice President-Product Development at Stallergenes SA from 2003 to 2012.
He then worked as Senior EVP-Clinical Development at DBV Technologies SA from 2015 to 2016.
Ruban holds an MBA from INSEAD and an undergraduate degree from Ecole Centrale Lyon.
Anciens postes connus de Charles Ruban
| Sociétés | Poste | Fin |
|---|---|---|
| DBV TECHNOLOGIES | Chief Operating Officer | 15/03/2019 |
| STALLERGENES | Chief Tech/Sci/R&D Officer | 04/08/2010 |
Formation de Charles Ruban
| INSEAD | Masters Business Admin |
| Ecole Centrale Lyon | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DBV TECHNOLOGIES | Health Technology |
| Entreprise privées | 1 |
|---|---|
Stallergenes SA
 Stallergenes SA Pharmaceuticals: MajorHealth Technology Stallergenes SA is an international biopharmaceutical company, which engages in the manufacture and sale of pharmaceutical products for the treatment of allergy-related respiratory diseases. The company operates through the Allergen Immunotherapy segment, which provides products and services for the desensitization of allergy-related respiratory conditions. Its products include a range of sublingual route and subcutaneous route products for the treatment of respiratory diseases such as rhino-conjunctivitis, rhinitis, and allergic asthma. Stallergenes was founded in 1962 and is headquartered in Antony, France. | Health Technology |
